Literature DB >> 7684894

Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

E Varecková1, V Mucha, F Ciampor, T Betáková, G Russ.   

Abstract

Haemagglutinin (HA) was detected on the surface of influenza virus infected cell with monoclonal antibodies (MAbs) against both HA glycopolypeptides, HA1 and HA2, however, the reactivity of HA2-specific MAbs was remarkably lower as compared with HA1-specific MAbs. Quantitative analysis with two MAbs, IB8 (anti-HA1) and IIF4 (anti-HA2) respectively, revealed that HA2 epitope was reachable for antibody only in minor subpopulation of the HA representing approximately 7% of all molecules (spikes). The basis of the HA heterogeneity is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684894     DOI: 10.1007/bf01318995

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Radioimmunoassay of influenza A virus haemagglutinin. I. Preparation and properties of radioactive 125I-labelled bromelain-released haemagglutinin.

Authors:  G Russ; B Styk; K Poláková
Journal:  Acta Virol       Date:  1978-01       Impact factor: 1.162

2.  Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2.

Authors:  F Kostolanský; B Styk; G Russ
Journal:  Acta Virol       Date:  1989-12       Impact factor: 1.162

3.  Immunodiffusion reaction with animal influenza viruses and antibody.

Authors:  B Styk; D Blaskovic
Journal:  Arch Exp Veterinarmed       Date:  1973

4.  Antigenic determinants of influenza virus hemagglutinin. V. Antigenicity of the HA2 chain.

Authors:  L E Brown; T A Dopheide; C W Ward; D O White; D C Jackson
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

5.  Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera.

Authors:  B Styk; G Russ; K Poláková
Journal:  Acta Virol       Date:  1979-01       Impact factor: 1.162

6.  The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus.

Authors:  P Poumbourios; L E Brown; D O White; D C Jackson
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

7.  Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. II. Reactivity with rabbit sera against intact virus and purified undissociated haemagglutinin.

Authors:  G Russ; B Styk; K Poláková
Journal:  Acta Virol       Date:  1978-09       Impact factor: 1.162

8.  Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants.

Authors:  P N Graves; J L Schulman; J F Young; P Palese
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

9.  Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.

Authors:  G Russ; K Poláková; F Kostolanský; B Styk; M Vancíková
Journal:  Acta Virol       Date:  1987-09       Impact factor: 1.162

10.  Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP).

Authors:  S M Hurtley; D G Bole; H Hoover-Litty; A Helenius; C S Copeland
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  8 in total

1.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells.

Authors:  P Vanlandschoot; E Beirnaert; S Neirynck; X Saelens; W M Jou; W Fiers
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus.

Authors:  Shahla Shahsavandi; Ali-Hatef Salmanian; Seyed Ali Ghorashi; Shahin Masoudi; Fatemeh Fotouhi; Mohammad Majid Ebrahimi
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

Review 4.  Development of a Universal Influenza Vaccine.

Authors:  Leonardo D Estrada; Stacey Schultz-Cherry
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

5.  A Unique Multibasic Proteolytic Cleavage Site and Three Mutations in the HA2 Domain Confer High Virulence of H7N1 Avian Influenza Virus in Chickens.

Authors:  El-Sayed M Abdelwhab; Jutta Veits; Kerstin Tauscher; Mario Ziller; Jens P Teifke; Jürgen Stech; Thomas C Mettenleiter
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 6.  Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic.

Authors:  Nathaniel Nyakaat Ninyio; Kok Lian Ho; Abdul Rahman Omar; Wen Siang Tan; Munir Iqbal; Abdul Razak Mariatulqabtiah
Journal:  Vaccines (Basel)       Date:  2020-11-19

7.  Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation.

Authors:  S A Wharton; L J Calder; R W Ruigrok; J J Skehel; D A Steinhauer; D C Wiley
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

8.  Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.

Authors:  Javier G Magadán; Meghan O Altman; William L Ince; Heather D Hickman; James Stevens; Aaron Chevalier; David Baker; Patrick C Wilson; Rafi Ahmed; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.